Updated:
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. is a family office based in Abingdon, United Kingdom, serving the wealth generated from the Oxford Immunotec diagnostics company.
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. is a family office based in Abingdon, United Kingdom, serving the wealth generated from the Oxford Immunotec diagnostics company. The firm was established to oversee the family's financial assets, with a primary focus on healthcare services and diagnostic testing. The office's investment strategy centers on direct and indirect allocations within the healthcare sector, leveraging the family's operational expertise from the diagnostics industry. The family's background includes the development and commercialization of T-cell-based testing, particularly for infectious diseases. Geographic focus remains in the United Kingdom and Europe, with portfolio companies largely in diagnostics and clinical immunology. There is no public data on the firm's AUM, professionals, or recent operational events. The firm maintains a low public profile, with minimal disclosure beyond its registration as a corporate entity. Philanthropic structures or adjacent vehicles have not been identified. The structural differentiator is likely the deep domain expertise in diagnostics and immunology, allowing the family office to invest with informed conviction in healthcare subsectors where the family's operational history provides proprietary insight.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Abingdon
Corporate office
Abingdon, United Kingdom
Sector focus
Frequently asked questions
What is the ownership and wealth origin behind Oxford Immunotec Ltd.?
Oxford Immunotec Ltd. is the single-family office for the family that founded Oxford Immunotec, a diagnostics company specializing in T-cell-based tests for infectious diseases. The wealth origin is the family's involvement in the clinical diagnostics industry, but specific principals are not publicly named (per public record).
What investment strategy does Oxford Immunotec Ltd. pursue?
Based on the firm's name and location, the office likely focuses on healthcare and life sciences investments, leveraging the family's operational experience in diagnostics. Direct investments and co-investments in private companies within the diagnostics and clinical immunology space are probable, though no specific deals are publicly confirmed.
How does Oxford Immunotec Ltd. source its deals?
Given the family's background in diagnostics, deal sourcing likely relies on industry networks and relationships built through Oxford Immunotec's operations. The firm may partner with specialist healthcare venture capital firms or co-invest alongside other family offices with similar sector focuses.
Is Oxford Immunotec Ltd. a single-family office or multi-family office?
Available public information designates Oxford Immunotec Ltd. as a single-family office, managing assets for the founding family of Oxford Immunotec. There is no evidence that it serves multiple families.
Does Oxford Immunotec Ltd. invest in funds or only direct deals?
The firm's investment style is not publicly documented. Given the family's industry domain, it may participate in both direct healthcare investments and fund commitments to life sciences funds, but no specific fund or direct deal activity has been disclosed.
What is the team size and who manages investments?
Team size and the names of investment professionals at Oxford Immunotec Ltd. are not public. The office maintains a low profile, and no individuals are listed on the firm's website or in corporate filings as managing investments.
Does Oxford Immunotec Ltd. have a philanthropic arm?
No philanthropic structures or foundations associated with Oxford Immunotec Ltd. have been identified in public records. The family may support charitable causes privately, but no such vehicles are documented under this entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: